Rituxan and BEAM With Autologous Peripheral Blood Progenitor Transplant for Indolent Lymphoma

NCT00572013 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: Rituxan
DRUG: BEAM
PROCEDURE: Autologous stem cell transplant

Sponsor

University of Nebraska